Literature DB >> 30728292

ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.

Sejeong Shin1, Gwen R Buel2,3, Michal J Nagiec2,3, Min-Joon Han4, Philippe P Roux5, John Blenis6,3, Sang-Oh Yoon7.   

Abstract

ERK is a key coordinator of the epithelial-to-mesenchymal transition (EMT) in that a variety of EMT-inducing factors activate signaling pathways that converge on ERK to regulate EMT transcription programs. However, the mechanisms by which ERK controls the EMT program are not well understood. Through an analysis of the global changes of gene expression mediated by ERK2, we identified the transcription factor FoxO1 as a potential mediator of ERK2-induced EMT, and thus we investigated the mechanism by which ERK2 regulates FoxO1. Additionally, our analysis revealed that ERK2 induced the expression of Dock10, a Rac1/Cdc42 GEF, during EMT. We demonstrate that the activation of the Rac1/JNK signaling axis downstream of Dock10 leads to an increase in FoxO1 expression and EMT. Taken together, our study uncovers mechanisms by which epithelial cells acquire less proliferative but more migratory mesenchymal properties and reveals potential therapeutic targets for cancers evolving into a metastatic disease state.

Entities:  

Keywords:  Dock10; EMT; ERK2; FoxO; epithelial-to-mesenchymal transition

Mesh:

Substances:

Year:  2019        PMID: 30728292      PMCID: PMC6386703          DOI: 10.1073/pnas.1811923116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

Review 2.  Epithelial plasticity: a common theme in embryonic and cancer cells.

Authors:  M Angela Nieto
Journal:  Science       Date:  2013-11-08       Impact factor: 47.728

Review 3.  Dock-family exchange factors in cell migration and disease.

Authors:  Gilles Gadea; Anne Blangy
Journal:  Eur J Cell Biol       Date:  2014-06-24       Impact factor: 4.492

4.  EMT in cancer.

Authors:  Thomas Brabletz; Raghu Kalluri; M Angela Nieto; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2018-01-12       Impact factor: 60.716

5.  In Vivo Visualization and Characterization of Epithelial-Mesenchymal Transition in Breast Tumors.

Authors:  Zhen Zhao; Xiaoping Zhu; Kemi Cui; James Mancuso; Richard Federley; Kari Fischer; Gaojun Teng; Vivek Mittal; Dingcheng Gao; Hong Zhao; Stephen Tc Wong
Journal:  Cancer Res       Date:  2016-02-18       Impact factor: 12.701

Review 6.  ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.

Authors:  Peijing Zhang; Yutong Sun; Li Ma
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation.

Authors:  Jer-Yen Yang; Cong S Zong; Weiya Xia; Hirohito Yamaguchi; Qingqing Ding; Xiaoming Xie; Jing-Yu Lang; Chien-Chen Lai; Chun-Ju Chang; Wei-Chien Huang; Hsin Huang; Hsu-Ping Kuo; Dung-Fang Lee; Long-Yuan Li; Huang-Chun Lien; Xiaoyun Cheng; King-Jen Chang; Chwan-Deng Hsiao; Fuu-Jen Tsai; Chang-Hai Tsai; Aysegul A Sahin; William J Muller; Gordon B Mills; Dihua Yu; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Nat Cell Biol       Date:  2008-01-20       Impact factor: 28.824

8.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.

Authors:  Lu Xie; Brian K Law; Anna M Chytil; Kimberly A Brown; Mary E Aakre; Harold L Moses
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

9.  EMT and tumor metastasis.

Authors:  Sarah Heerboth; Genevieve Housman; Meghan Leary; Mckenna Longacre; Shannon Byler; Karolina Lapinska; Amber Willbanks; Sibaji Sarkar
Journal:  Clin Transl Med       Date:  2015-02-26

10.  Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Authors:  Xiaofeng Zheng; Julienne L Carstens; Jiha Kim; Matthew Scheible; Judith Kaye; Hikaru Sugimoto; Chia-Chin Wu; Valerie S LeBleu; Raghu Kalluri
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

View more
  24 in total

1.  Dynamic Incorporation of Histone H3 Variants into Chromatin Is Essential for Acquisition of Aggressive Traits and Metastatic Colonization.

Authors:  Ana P Gomes; Didem Ilter; Vivien Low; Adam Rosenzweig; Zih-Jie Shen; Tanya Schild; Martin A Rivas; Ekrem E Er; Dylan R McNally; Anders P Mutvei; Julie Han; Yi-Hung Ou; Paola Cavaliere; Edouard Mullarky; Michal Nagiec; Sejeong Shin; Sang-Oh Yoon; Noah Dephoure; Joan Massagué; Ari M Melnick; Lewis C Cantley; Jessica K Tyler; John Blenis
Journal:  Cancer Cell       Date:  2019-09-26       Impact factor: 31.743

2.  Immunohistochemical expressions of EMT markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.

Authors:  Kiran Tripathi; Niharika Maurya; Apul Goel; Atin Singhai; Minal Garg
Journal:  Mol Cell Biochem       Date:  2022-10-14       Impact factor: 3.842

Review 3.  Emerging roles of circular RNAs in gastric cancer metastasis and drug resistance.

Authors:  Xiaolin Wang; Jiahui Zhang; Guozhen Cao; Jinghan Hua; Ge Shan; Wenchu Lin
Journal:  J Exp Clin Cancer Res       Date:  2022-07-11

4.  Exosomal miR-27b-3p Derived from Hypoxic Cardiac Microvascular Endothelial Cells Alleviates Rat Myocardial Ischemia/Reperfusion Injury through Inhibiting Oxidative Stress-Induced Pyroptosis via Foxo1/GSDMD Signaling.

Authors:  Baojian Zhang; Chao Sun; Yaozhong Liu; Fan Bai; Tao Tu; Qiming Liu
Journal:  Oxid Med Cell Longev       Date:  2022-07-06       Impact factor: 7.310

5.  KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.

Authors:  Chaitra Rao; Danielle E Frodyma; Siddesh Southekal; Robert A Svoboda; Adrian R Black; Chittibabu Guda; Tomohiro Mizutani; Hans Clevers; Keith R Johnson; Kurt W Fisher; Robert E Lewis
Journal:  Elife       Date:  2021-05-10       Impact factor: 8.140

6.  Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer.

Authors:  Jianpo Lian; Chengdang Xu; Xi Chen; Shengsong Huang; Denglong Wu
Journal:  J Cancer Res Clin Oncol       Date:  2022-03-23       Impact factor: 4.553

7.  Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis.

Authors:  Rafael Parra-Medina; Liliana López-Kleine; Sandra Ramírez-Clavijo; César Payán-Gómez
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

Review 8.  Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond.

Authors:  Shing Yau Tam; Vincent W C Wu; Helen K W Law
Journal:  Front Oncol       Date:  2020-04-08       Impact factor: 6.244

Review 9.  Subcellular Localization Relevance and Cancer-Associated Mechanisms of Diacylglycerol Kinases.

Authors:  Antonietta Fazio; Eric Owusu Obeng; Isabella Rusciano; Maria Vittoria Marvi; Matteo Zoli; Sara Mongiorgi; Giulia Ramazzotti; Matilde Yung Follo; James A McCubrey; Lucio Cocco; Lucia Manzoli; Stefano Ratti
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

Review 10.  FOXO transcription factor family in cancer and metastasis.

Authors:  Yannasittha Jiramongkol; Eric W-F Lam
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.